Werkgroep Cardiologische centra Nederland

Stability LPL II (Completed)

A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Medicine
darapladib
Population
ASCVD
Phase
III
Starting year
2009
More information
ClinivalTrials.gov

Director of Study

drs. H.P. Swart (Cardioloog)
Sneek, D&A Research and Genetics

Stability LPL II: News